Epidemiology and Clinical Presentation of H1N1 Infection in Children in Geneva

Completed

• Conditions: Healthy; Immunosuppressed; Asthmatic; Neuromuscular Diseases

• Registration Number: NCT01022931
• Lead Sponsor: University Hospital, Geneva

Brief Summary

This study aims to identify clinical symptoms and outcomes, as well as response to anti-viral treatment in children living in Geneva, with influenza A/ H1N1 infection during the current pandemic.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-10
• Study First Submitted: 2009-11-30
• Study First Submitted QC: 2009-11-30
• Study First Posted: 2009-12-01
• Primary Completion: 2010-02
• Study Completion: 2012-07
• Status Verified: 2012-12
• Last Update Submitted: 2012-12-10
• Last Update Posted: 2012-12-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• suspicion of H1N1 infection

Exclusion Criteria

• Not available for a 30 days follow-up

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ABCB1 polymorphisms	6 months	ABCB1 gene polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia

Trial Locations

Locations (1)

Children's Hospital of Geneva, HUG; 🇨🇭 Geneva, GE, Switzerland